表紙
市場調查報告書

中國體外診斷 (IVD) 市場分析:未來預測 (至2023年)

Chinese In-vitro Diagnostics Market Insight, Forecast to 2023

出版商 Frost & Sullivan 商品編碼 877674
出版日期 內容資訊 英文 65 Pages
商品交期: 最快1-2個工作天內
價格
中國體外診斷 (IVD) 市場分析:未來預測 (至2023年) Chinese In-vitro Diagnostics Market Insight, Forecast to 2023
出版日期: 2019年06月21日內容資訊: 英文 65 Pages
簡介

中國體外診斷 (IVD) 市場規模受到人口高齡化與可用所得上升、醫療制度改革等因素影響、預計今後將更進一步的擴大。另外、市場也開始二極化、高端產品由外資企業獨佔、國內企業預計將持續依賴低價產品。

本報告針對中國國內體外診斷 (IVD) 市場分析、提供市場全體構造與促進、阻礙因素、全體市場動向預測 (今後5年份)、種類分類 (免疫化學、分子診斷、POCT) 詳細動向、主要企業市場佔有率構造、今後成長機會方向、規模等調查。

摘要整理

市場促進、阻礙因素

  • 市場促進因素
  • 市場阻礙因素
  • 中國體外診斷 (IVD) 市場:概要
  • 市場概略

中國體外診斷 (IVD) 市場:市場預測

  • 市場收益額預測

競爭環境

  • 市場競爭環境

成長機會與法規考慮事項 (主要3種分類):中國IVD市場

  • 臨床診斷的成長機會
  • 中國國內法規進展
  • IVD供應商的策略課題

免疫化學 - 種類分類分析

  • 機會與課題:流通管道數位化
  • 市場收益額預測
  • 市場佔有率分析

分子診斷 - 種類分類分析

  • 成長機會:NGS
  • 市場收益額預測
  • 市場佔有率分析

POCT - 種類分類分析

  • 成長機會:市場連結用可攜式POCT方案
  • 市場收益額預測
  • 市場佔有率分析

未來主要預測與結論

  • 中國IVD市場相關主要預測
  • 主要結論

附錄:中國IVD市場

關於Frost & Sullivan

目錄
Product Code: 9AB9/87

The China Manufacturing 2025 Program for Promoting Local R&D Investments and Increasing Demand from Tier I and II Hospitals Set to Transform the Industry Landscape

The In-vitro Diagnostics (IVD) market in China shows strong growth potential in several segments. Market growth is set to be driven by the growing volume of tests, rather than the higher price of testing solutions in traditional segments and the popularization of advanced testing technology in emerging segments. In the context of the reform in public hospitals, the IVD industry is the direct beneficiary of the drug price policy and is expected to acquire strong growth potential in the long run. On the supply side, foreign companies are dominating the high-end market by leveraging their technical advantage to develop closed-end systems for their automatic analyzers. However, owing to their lack of input on distribution channels and their high-priced products, they are likely to find it difficult to penetrate the lower-end hospitals in the short term.

The IVD market in China presents a diversified growth potential for the different tiers of competitors: domestic participants gain from the growth momentum for the low-end market, whereas leading foreign manufacturers dominate the high-end market, which is expected to become the new emerging market along with ever-improving localized services to meet various demands. The mid-to-low-end market is crowded with local participants, leading to fierce competition.

China is currently facing severe shortage of anatomic pathologists, which blocks patients' access to quality care. The relatively small number of pathologists are often overworked. Moreover, the penetration of IVD devices has been on the lower side. China has not yet issued a regulation on management standards for independent clinical laboratories. This leads to each laboratory developing its own standards that are not uniform and providing a narrow scope of services (which is not in line with accepted clinical laboratory standards). Overall, the substitution devices developed by local companies are the most important factor in increasing the IVD market size, as it improves the accessibility of lower-end hospitals to advanced IVD technologies, boosting their need to update IVD products.

Key Issues Addressed:

  • What are the key healthcare trends that can impact the Chinese IVD market?
  • What are the drivers and restraints impacting market growth?
  • What are the unmet needs and opportunities for the existing and emerging participants?
  • What are the segment shares of key market participants?
  • How are companies dealing with the market challenges?
  • What are the future trends and forecast scenario for IVD in China?

Table of Contents

Executive Summary

  • Key Findings
  • Scope and Segmentation
  • Key Questions this Study will Answer
  • Chinese IVD Market Attractiveness Matrix by Segment
  • Chinese IVD Market Attractiveness

Market Drivers and Restraints

  • Market Drivers
  • Market Restraints
  • Chinese IVD Market-An Overview
  • Market Overview

Chinese IVD Market-Market Forecast

  • Revenue Forecast Discussion

Competitive Environment

  • Competitive Environment

Growth Opportunities and Regulatory Consideration (Top 3 Segments)-Chinese IVD Market

  • Growth Opportunities in Clinical Diagnostics
  • Regulatory Developments in China
  • Strategic Imperatives for IVD Vendors

Immunochemistry-Segment Breakdown

  • Opportunities and Challenges-Digitalization of Distribution Channels
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Share Analysis

Molecular Diagnostics-Segment Breakdown

  • Growth Opportunity-Next-generation Sequencing (NGS)
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Share Analysis

POCT-Segment Breakdown

  • Growth Opportunity-Portable POCT solutions for Market Access
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Share Analysis

Top Predictions and Conclusion

  • Top Predictions for the Chinese IVD Market
  • Key Conclusion
  • Legal Disclaimer

Appendix-Chinese IVD Market

  • Timeline of Key Reforms Driving Private Sector Participation
  • Health Insurance Programs in China-An Overview
  • Healthy China 2020 Initiative-An Overview
  • Total Healthcare Spending in China
  • Encouraging Private Foreign Investments in China's Hospital System
  • Allowing Physicians to Practice at Multiple Sites
  • Allowing Public Hospital Patients to be Treated in Private Hospitals
  • Providing Structured Guidelines for Medical Devices and Clinical Tests
  • Market Attractiveness-Key Parameters
  • Market Attractiveness-Key Parameters (continued)
  • List of Exhibits
  • List of Exhibits (continued)

The Frost & Sullivan Story

  • The Frost & Sullivan Story
  • Value Proposition: Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360° Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy